FDA Adverse Event Injury Summary report: N

VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT

MDR report key: 9376522 · Received November 26, 2019

Report

Report Number
2210968-2019-90314
Event Type
Injury
Date Received
November 26, 2019
Report Date
November 6, 2019
Manufacturer
ETHICON INC.
Product Code
GAM
PMA / PMN Number
K022269
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. CITATION: AUST NZ OBSTET GYNECOLOGY. 2001; 41(3): 307. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED VIA JOURNAL ARTICLE: TITLE : TOTAL LAPAROSCOPIC HYSTERECTOMY WITH LAPAROSONIC COAGULATING SHEARS: A RETROSPECTIVE REPORT OF 200 CONSECUTIVE CASES. AUTHOR : GREGORY M CARIO AND MARK A CARLTON. CITATION: AUST NZ OBSTET GYNECOLOGY. 2001; 41(3): 307. THE AUTHORS BELIEVED THAT THE TOTAL LAPAROSCOPIC HYSTERECTOMY (TLH) PROCEDURE SHOULD BECOME THE STANDARD PROCEDURE FOR TREATMENT OF BENIGN UTERINE DISEASE, AS THE LAPAROSCOPIC OPERATION HAS FOR ECTOPIC PREGNANCY, AND THE LAPAROSCOPIC CHOLECYSTECTOMY FOR BENIGN GALLBLADDER DISEASE. THE AUTHORS PRESENTED A SERIES OF 200 CONSECUTIVE CASES OF TLH. THE OBJECTIVES OF THE STUDY WAS TO EVALUATE 200 CONSECUTIVE CASES (AGE RANGE: 30 TO 78 YEARS OLD) OF TOTAL HYSTERECTOMY USING THE LAPAROSCOPIC COAGULATING SHEARS (LCS). DISSECTION OF THE BLADDER PERITONEUM AND MOBILIZATION OF THE BLADDER WAS ALSO PERFORMED WITH THE LCS. THE UTERINE ARTERY WAS SKELETONISED WITH THE LCS AND SUTURED BILATERALLY WITH A PDS-0 SUTURE (ETHICON) ON A CURVED NEEDLE. COLPOTOMY WAS PERFORMED WITH THE LCS AND HARMONIC SCALPEL (ETHICON) HOOK OVER THE COLPOTOMY TUBE. THE VAGINAL VAULT WAS SUTURED WITH VICRYL-0 SUTURES (ETHICON) IN THE ANGLES AND TWO ¿FIGURE OF 8¿ MONOCRYL-0 SUTURES (ETHICON) IN THE MIDLINE. VAULT SUSPENSION WAS COMPLETED WITH AT LEAST ONE HIGH MCCALL VAULT SUTURE USING DERMALON-0 (ETHICON). REPORTED COMPLICATIONS INCLUDED HEMORRHAGE (N-2) WHICH WERE TREATED INTRAOPERATIVELY USING LAPAROSCOPIC TECHNIQUES AND INFECTED VAULT HEMATOMA (N-7) WHICH REQUIRED ORAL OR INTRAVENOUS ANTIBIOTICS. THE TECHNICAL IMPROVEMENT IN THIS PROCEDURE USING THE LCS AND THE COLPOTOMISER, WITH ACCEPTABLE OPERATING TIME AND COMPLICATION RATES SHOULD MAKE THIS A ROUTINE PROCEDURE FOR HYSTERECTOMY WITH BENIGN PATHOLOGY AND SHOULD REDUCE THE NEED FOR LAVH, VH AND, MOST IMPORTANTLY, ABDOMINAL HYSTERECTOMY. THE GREAT ADVANTAGES OF MINIMALLY INVASIVE SURGERY, INCLUDING THE BENEFIT TO THE COMMUNITY, MEAN THAT TLH SHOULD BE OFFERED FREELY AS AN ALTERNATIVE TO WOMEN CONSIDERING HYSTERECTOMY AND SHOULD BE MORE WIDELY AVAILABLE IN THE COMMUNITY WITH AN UPTAKE CLOSER TO 70% THAN 10%.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1172450 VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT SUTURE, ABSORBABLE, SYNTHETIC GAM ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention